![]() | |
Names | |
---|---|
Preferred IUPAC name 2-(2H,6H-[1,3]Dioxolo[4,5-e]indol-8-yl)-N,N-dimethylethan-1-amine | |
Other names 4,5-Methylenedioxy-N,N-dimethyltryptamine | |
Identifiers | |
3D model (JSmol) | |
ChEMBL | |
ChemSpider |
|
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C13H16N2O2 | |
Molar mass | 232.283 g·mol−1 |
Melting point | 93–95 °C (199–203 °F; 366–368 K) [1] |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
4,5-MDO-DMT, or 4,5-methylenedioxy-N,N-dimethyltryptamine, is a lesser-known psychedelic drug. It is the 4,5-methylenedioxy analog of DMT. 4,5-MDO-DMT was first synthesized by Alexander Shulgin, though in his book TiHKAL it was not tested to determine its psychoactive effects. 4,5-MDO-DMT has been the subject of limited subsequent testing; with behavioral disruption studies performed in male rats indicating that its hallucinogenic potency is less than that of 4,5-MDO-DiPT but greater than that of 5,6-MDO-DiPT. [1]
Tryptamines |
|
---|---|
4-Hydroxytryptamines and esters/ethers |
|
5-Hydroxy- and 5-methoxytryptamines |
|
N-Acetyltryptamines |
|
α-Alkyltryptamines |
|
Triptans | |
Cyclized tryptamines |
|
Isotryptamines | |
Related compounds |
|
![]() | This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |